Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review.

Saylor M, McLoon LK, Harrison AR, Lee MS.

Arch Ophthalmol. 2009 Apr;127(4):402-6. doi: 10.1001/archophthalmol.2009.9. Review.

PMID:
19365015
2.

Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma.

Wheeler LA, Gil DW, WoldeMussie E.

Surv Ophthalmol. 2001 May;45 Suppl 3:S290-4; discussion S295-6.

PMID:
11377451
3.

Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma.

Wheeler LA, Woldemussie E.

Eur J Ophthalmol. 2001 Jul-Sep;11 Suppl 2:S30-5.

PMID:
11592528
4.
5.

Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy.

Danylkova NO, Alcala SR, Pomeranz HD, McLoon LK.

Exp Eye Res. 2007 Feb;84(2):293-301. Epub 2006 Nov 16.

PMID:
17113077
6.

Role of alpha-2 agonists in neuroprotection.

Wheeler L, WoldeMussie E, Lai R.

Surv Ophthalmol. 2003 Apr;48 Suppl 1:S47-51. Review.

PMID:
12852434
7.

Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells.

Gao H, Qiao X, Cantor LB, WuDunn D.

Arch Ophthalmol. 2002 Jun;120(6):797-803.

PMID:
12049586
8.

Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.

Yoles E, Wheeler LA, Schwartz M.

Invest Ophthalmol Vis Sci. 1999 Jan;40(1):65-73. Erratum in: Invest Ophthalmol Vis Sci 199 Oct;40(11):2470.

PMID:
9888428
9.

Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model.

Aktaş Z, Gürelik G, Akyürek N, Onol M, Hasanreisoğlu B.

Clin Experiment Ophthalmol. 2007 Aug;35(6):527-34.

PMID:
17760634
10.

The growth factor response in ischemic rat retina and superior colliculus after brimonidine pre-treatment.

Lönngren U, Näpänkangas U, Lafuente M, Mayor S, Lindqvist N, Vidal-Sanz M, Hallböök F.

Brain Res Bull. 2006 Dec 11;71(1-3):208-18. Epub 2006 Oct 2.

PMID:
17113948
11.

Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.

Dong CJ, Guo Y, Agey P, Wheeler L, Hare WA.

Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4515-22. doi: 10.1167/iovs.08-2078. Epub 2008 Jun 19.

PMID:
18566471
12.

Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.

WoldeMussie E, Ruiz G, Wijono M, Wheeler LA.

Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2849-55.

PMID:
11687528
13.

Evaluation of neuroprotective qualities of brimonidine during LASIK.

McCarty TM, Hardten DR, Anderson NJ, Rosheim K, Samuelson TW.

Ophthalmology. 2003 Aug;110(8):1615-25.

PMID:
12917182
14.

RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.

Levkovitch-Verbin H, Harris-Cerruti C, Groner Y, Wheeler LA, Schwartz M, Yoles E.

Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4169-74.

PMID:
11095611
15.

Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina.

Baptiste DC, Hartwick AT, Jollimore CA, Baldridge WH, Chauhan BC, Tremblay F, Kelly ME.

Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2666-76.

PMID:
12147601
16.

Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death.

Vidal-Sanz M, Lafuente MP, Mayor-Torroglosa S, Aguilera ME, Miralles de Imperial J, Villegas-Pérez MP.

Eur J Ophthalmol. 2001 Jul-Sep;11 Suppl 2:S36-40.

PMID:
11592529
17.

Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model.

Ma K, Xu L, Zhang H, Zhang S, Pu M, Jonas JB.

Am J Ophthalmol. 2009 Feb;147(2):326-31. doi: 10.1016/j.ajo.2008.08.005. Epub 2008 Oct 4.

PMID:
18835468
18.

Possible neuroprotective effect of brimonidine in a mouse model of ischaemic optic neuropathy.

Goldenberg-Cohen N, Dadon-Bar-El S, Hasanreisoglu M, Avraham-Lubin BC, Dratviman-Storobinsky O, Cohen Y, Weinberger D.

Clin Experiment Ophthalmol. 2009 Sep;37(7):718-29. doi: 10.1111/j.1442-9071.2009.02108.x.

PMID:
19788670
19.

Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes.

Acheampong AA, Shackleton M, John B, Burke J, Wheeler L, Tang-Liu D.

Drug Metab Dispos. 2002 Apr;30(4):421-9.

20.

Preclinical evaluation of brimonidine.

Burke J, Schwartz M.

Surv Ophthalmol. 1996 Nov;41 Suppl 1:S9-18. Review.

PMID:
8970245
Items per page

Supplemental Content

Write to the Help Desk